235 related articles for article (PubMed ID: 25210032)
21. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival.
Chien Y; White MA
EMBO Rep; 2003 Aug; 4(8):800-6. PubMed ID: 12856001
[TBL] [Abstract][Full Text] [Related]
22. Expression of ral GTPases, their effectors, and activators in human bladder cancer.
Smith SC; Oxford G; Baras AS; Owens C; Havaleshko D; Brautigan DL; Safo MK; Theodorescu D
Clin Cancer Res; 2007 Jul; 13(13):3803-13. PubMed ID: 17606711
[TBL] [Abstract][Full Text] [Related]
23. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK
Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207
[TBL] [Abstract][Full Text] [Related]
24. RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer.
Khawaja H; Campbell A; Roberts JZ; Javadi A; O'Reilly P; McArt D; Allen WL; Majkut J; Rehm M; Bardelli A; Di Nicolantonio F; Scott CJ; Kennedy R; Vitale N; Harrison T; Sansom OJ; Longley DB; Evergren E; Van Schaeybroeck S
Cell Death Dis; 2020 Oct; 11(10):930. PubMed ID: 33122623
[TBL] [Abstract][Full Text] [Related]
25. RalA, a GTPase targeted by miR-181a, promotes transformation and progression by activating the Ras-related signaling pathway in chronic myelogenous leukemia.
Gu C; Feng M; Yin Z; Luo X; Yang J; Li Y; Li T; Wang R; Fei J
Oncotarget; 2016 Apr; 7(15):20561-73. PubMed ID: 26967392
[TBL] [Abstract][Full Text] [Related]
26. The RAL Enigma: Distinct Roles of RALA and RALB in Cancer.
Richardson DS; Spehar JM; Han DT; Chakravarthy PA; Sizemore ST
Cells; 2022 May; 11(10):. PubMed ID: 35626682
[TBL] [Abstract][Full Text] [Related]
27. Solution structure and dynamics of the small GTPase RalB in its active conformation: significance for effector protein binding.
Fenwick RB; Prasannan S; Campbell LJ; Nietlispach D; Evetts KA; Camonis J; Mott HR; Owen D
Biochemistry; 2009 Mar; 48(10):2192-206. PubMed ID: 19166349
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation by protein kinase Cα regulates RalB small GTPase protein activation, subcellular localization, and effector utilization.
Martin TD; Mitin N; Cox AD; Yeh JJ; Der CJ
J Biol Chem; 2012 Apr; 287(18):14827-36. PubMed ID: 22393054
[TBL] [Abstract][Full Text] [Related]
29. RalA suppresses early stages of Ras-induced squamous cell carcinoma progression.
Sowalsky AG; Alt-Holland A; Shamis Y; Garlick JA; Feig LA
Oncogene; 2010 Jan; 29(1):45-55. PubMed ID: 19802010
[TBL] [Abstract][Full Text] [Related]
30. Ral GTPase Activation by Downregulation of RalGAP Enhances Oral Squamous Cell Carcinoma Progression.
Gao P; Liu S; Yoshida R; Shi CY; Yoshimachi S; Sakata N; Goto K; Kimura T; Shirakawa R; Nakayama H; Sakata J; Kawashiri S; Kato K; Wang XY; Horiuchi H
J Dent Res; 2019 Aug; 98(9):1011-1019. PubMed ID: 31329042
[TBL] [Abstract][Full Text] [Related]
31. RalA is overactivated in medulloblastoma.
Ginn KF; Fangman B; Terai K; Wise A; Ziazadeh D; Shah K; Gartrell R; Ricke B; Kimura K; Mathur S; Borrego-Diaz E; Farassati F
J Neurooncol; 2016 Oct; 130(1):99-110. PubMed ID: 27566179
[TBL] [Abstract][Full Text] [Related]
32. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
Thies KA; Cole MW; Schafer RE; Spehar JM; Richardson DS; Steck SA; Das M; Lian AW; Ray A; Shakya R; Knoblaugh SE; Timmers CD; Ostrowski MC; Chakravarti A; Sizemore GM; Sizemore ST
Breast Cancer Res; 2021 Jun; 23(1):65. PubMed ID: 34118960
[TBL] [Abstract][Full Text] [Related]
33. RalB directly triggers invasion downstream Ras by mobilizing the Wave complex.
Zago G; Veith I; Singh MK; Fuhrmann L; De Beco S; Remorino A; Takaoka S; Palmeri M; Berger F; Brandon N; El Marjou A; Vincent-Salomon A; Camonis J; Coppey M; Parrini MC
Elife; 2018 Oct; 7():. PubMed ID: 30320548
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma.
Tian L; Zhao L; Sze KM; Kam CS; Ming VS; Wang X; Zhang VX; Ho DW; Cheung TT; Chan LK; Ng IO
Hepatology; 2022 Jul; 76(1):48-65. PubMed ID: 34767674
[TBL] [Abstract][Full Text] [Related]
35. Ral activation promotes melanomagenesis.
Zipfel PA; Brady DC; Kashatus DF; Ancrile BD; Tyler DS; Counter CM
Oncogene; 2010 Aug; 29(34):4859-64. PubMed ID: 20562921
[TBL] [Abstract][Full Text] [Related]
36. RalA and RalB function as the critical GTP sensors for GTP-dependent exocytosis.
Li G; Han L; Chou TC; Fujita Y; Arunachalam L; Xu A; Wong A; Chiew SK; Wan Q; Wang L; Sugita S
J Neurosci; 2007 Jan; 27(1):190-202. PubMed ID: 17202486
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.
Smith SC; Baras AS; Owens CR; Dancik G; Theodorescu D
Cancer Res; 2012 Jul; 72(14):3480-91. PubMed ID: 22586063
[TBL] [Abstract][Full Text] [Related]
38. Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling.
Feldmann G; Mishra A; Hong SM; Bisht S; Strock CJ; Ball DW; Goggins M; Maitra A; Nelkin BD
Cancer Res; 2010 Jun; 70(11):4460-9. PubMed ID: 20484029
[TBL] [Abstract][Full Text] [Related]
39. The p53-p21WAF1 checkpoint pathway plays a protective role in preventing DNA rereplication induced by abrogation of FOXF1 function.
Lo PK; Lee JS; Sukumar S
Cell Signal; 2012 Jan; 24(1):316-24. PubMed ID: 21964066
[TBL] [Abstract][Full Text] [Related]
40. Ral-Arf6 crosstalk regulates Ral dependent exocyst trafficking and anchorage independent growth signalling.
Pawar A; Meier JA; Dasgupta A; Diwanji N; Deshpande N; Saxena K; Buwa N; Inchanalkar S; Schwartz MA; Balasubramanian N
Cell Signal; 2016 Sep; 28(9):1225-1236. PubMed ID: 27269287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
